New Calculator Aims to Personalize Statin Decisions

Researchers at the University of Oxford have created a new calculator that estimates a person’s individual risk of developing serious muscle disorders while taking statins. The tool is designed to help patients and doctors make more informed decisions about these commonly prescribed cholesterol-lowering medications, which are widely used to prevent heart attacks and strokes.

The research, published in The Lancet Digital Health, found that more than 98% of people identified by their general practitioners as eligible for statin therapy were at low predicted risk of developing a serious muscle disorder over the following 10 years. The findings suggest that fears about severe muscle-related side effects may be overstated for most people who could benefit from treatment.

Putting Statin Side Effects into Perspective

Statins are among the most commonly prescribed medications for preventing cardiovascular disease. However, worries about muscle-related side effects often discourage people from starting treatment or lead them to stop taking the medication, even when the potential benefits are substantial.

The researchers emphasized that their work focuses only on serious muscle disorders that result in hospital admission or death, not the milder muscle aches and pains that some people experience. Previous research has shown that many mild muscle symptoms reported during statin treatment are not actually caused by statins and should not prevent patients from beginning therapy. Although serious muscle disorders are much less common, understanding the possibility of these rare events remains important when balancing the risks and benefits of treatment.

Personalized Risk Could Improve Treatment Decisions

Treatment decisions are often based on estimates of a person’s future cardiovascular risk, but much less information is available about their individual risk of adverse outcomes. This research helps address that gap by providing a way to estimate a person’s risk of serious muscle disorders alongside their cardiovascular risk.

By offering personalized estimates of both potential benefits and risks, the researchers hope the calculator will help patients and healthcare providers make more confident, evidence-based decisions about statin treatment and long-term cardiovascular disease prevention.

The Calculator and Its Development

The calculator, available through the Oxford University Innovation software store, is based on a clinical prediction model developed and tested using anonymized health records from more than 5.6 million people registered with GP practices across England. Researchers built the model using data from more than 1.7 million people and then validated its accuracy with records from another 3.9 million.

The model analyzes 22 routinely collected health factors to estimate the likelihood of developing a serious muscle disorder over one, five, and 10 years. These factors include age, sex, ethnicity, body mass index, smoking status, existing medical conditions, previous muscle problems, vitamin D deficiency, medication use, and whether a person has been prescribed statins.

Improving Conversations Between Patients and Clinicians

The researchers believe the new calculator could improve conversations between patients and clinicians by providing personalized estimates of risk instead of relying on general statistics or broad concerns about side effects. The tool could help clinicians have clearer discussions with patients about monitoring, checks, or alternative treatment options.

For the small number of people at higher risk, the calculator gives clinicians a clearer basis for discussing these options. By understanding a person’s risk, clinicians can provide more tailored guidance and support, helping patients make informed decisions about their care.